期刊文献+

尼美舒利对肝癌细胞生长的影响 被引量:4

The effect of nimesulide on human hepatocellular carcinoma cell line
暂未订购
导出
摘要 目的:探讨选择性环氧化酶-2(COX-2)抑制剂尼美舒利对肝癌细胞HepG2生长的影响。方法:MTs法检测对照组和实验组(尼美舒利25、50、100、200、400μmol/L)作用后HepG2细胞增殖变化;细胞侵袭小室法检测尼美舒利对HepG2迁移作用的影响。结果:对肝癌细胞HepG2的增殖有抑制作用,且呈剂量依赖性,尼美舒利对HepG2细胞迁移有明显抑制作用。结论:选择性环氧化酶2抑制剂尼美舒利可以抑制肝癌细胞的增殖和迁移。 Objective:To investigate the effect of selective Cyclooxygenase-2(COX-2) inhibitor,nimesulide,on human hepatocellular carcinoma HepG2 cell line.Methods: HepG2 cells were treated with various concentrations of nimesulide(25,50,100,200,400μmol/L),to detect the effect of proliferation by using MTS,and the migration was determined by transwell chamber.Results: Nimesulide inhibited the proliferation of HepG2 cell in a concentrationsdependent manner.The result of transwell chamber showed that nimesulide had a significant inhibitory action on HepG2.Conclusion: Nimesulide inhibits the proliferation and migration of hepatoma carcinoma cell.
出处 《现代肿瘤医学》 CAS 2010年第10期1913-1915,共3页 Journal of Modern Oncology
基金 宁夏科技攻关项目(编号:2008)
关键词 COX-2抑制剂 肝癌细胞 抑制作用 COX-2 inhibitor hepatoma carcinoma cell inhibitory
  • 相关文献

参考文献12

  • 1黄国民,乔士兴,房学东,刘林林.尼美舒利对人胃癌SGC7901细胞生长及细胞周期分布的影响[J].中国实验诊断学,2009,13(3):321-323. 被引量:5
  • 2Harris RE,Chlebowski RT,Jackson RD,et al.Breast cancer and nonsteroidal anti-inflammatory drugs:prospective results from the women's health initiative[J].Cancer Res,2003,63(18):6096-6101.
  • 3温士旺,李军霞,张少为,李勇,刘磊,张月峰,高立平.尼美舒利抑制肺腺癌细胞增殖机制研究[J].河北医药,2009,31(13):1560-1563. 被引量:3
  • 4Rainsford KD.Anti-inflammatory drugs in the 21st century[J].Subcell Biochem,2007,42:3-27.
  • 5Sung YK,Hwang SY,Kim JO,et al.The correlation between cyclooxygenase-2 expression and hepatocellular carcinogenesis[J].Mol Cells,2004,29,17 (1):35-38.
  • 6Cheng ASL,Chan HLY,Leung NWY,et al.Expression of cyclooxygenase-2 in chronic hepatitis B and the effects of anti-viral therapy[J].Aliment Pharmacol Ther,2002,16(2):251-260.
  • 7Shariat SF,Kim JH,Ayala GE,et al.Cyclooxygenase-2 highly expressed in arcinoma in situ and T1 transitional cell carcinoma of the bladder[J].J Urol,2003,169(3):938-942.
  • 8Chen WS,Liu JH,Wei SJ,et al.Colon cancer cells with high invasive potential are susceptible to induction of apoptosis by a selective COX-2 inhibitor[J].Cancer Sci,2003,94(3):253-258.
  • 9Han C,Leng J,Demetris AJ,et al.Cyclooxygenase-2 promotes human cholangiocarcinoma growth:evidence for cyclooxyegnase-2-independent mechanism in celecoxib-mediated induction of P21wafl/cipl and P27kiP1 and cell cycle arrest[J].Cancer Res,2004,64(4):1369-1376.
  • 10Ding H,Han C,Zhu J,et al.Celecoxib derivatives induce apoptosis via the disruption of mitochondrial membrane potential and activation of caspase 9[J].Int J Cancer,2005,113(5):803-810.

二级参考文献18

  • 1Yao M,Zhou W, Sangha S, et al. Effects of nonselective cyclooxygenase inhibition with low-dose ibuprofen on tumor growth, angiogenesis, metastasis, and survival in a mouse modal of colorectalcancer[J]. Clin Cancer Res,2005,11 : 1618.
  • 2Shaik MS, Chatteljee A, Singh M. Effect of a selective Cyclooxygenase-2 inhibitor, nimesulide on the growth of lung tumors and their expression of cyclooxygenase-2 and peroxisome proliferators-activated receptor gammal [J].Clin Cancer Res,2004,10:1521.
  • 3Lee DW,Sung MW,Park SW,et al.Increased cyclooxygenase-2expression in human squamous cell carcinomas of the head andneck and inhibition of proliferation by nonsteroidal anti-Ainflammatory drugs [ J ]. Anticancer Res,2006,22(4) :2089.
  • 4Dander DS, Lopez M, CareyRI, et al. Cyclooxygenase-2 inhibitor celecoxib augments chemotherapeutic drug-induced apoptosis by enhancing activa- tion of caspase-3 and-9 in prostate cancer cells[J]. Int J Cancer,2005,15 (3) :484.
  • 5Corcoran CA, He Q, Huang Y, et al. Cyclooxygenase-2 interacts with p53 and interferes with p53-dependent transcription and apoptosis[J]. Oncogene,2005,24:1634.
  • 6Courtney ED, Melville DM, Leicester RJ. Review article chemoprevention of colorectal cancel[J]. Aliment Pharmacol Ther,2004,19(1) : 1.
  • 7Hida T,Yatabe Y,Achiwa H,et al.Increased expression of cyclooxygenase 2 occurs frequently in human lung cancers,specifically in adenocarcinomas.Cancer Res,1998,58:3761-3764.
  • 8Yao M,Kargman S,Lam EC,et al.Inhibition of cyclooxygenase-2 by rofecoxib attenuates the growth and metastatic potential of colorectal carcinoma in mice.Cancer Res,2003,63:586-592.
  • 9TsubouchiY,Mukai S,Kawahito Y,et al.Meloxicam inhibits the growth of non-small cell lung cancer.Anticancer Res,2000,20:2867-2872.
  • 10Llewellyn-Jones CG,Lomas DA,Stockley RA.Potential role of recombinant secretory leucoprotease inhibitor in the prevention of neutrophil mediated matrix degradation.Thorax,1994,49:567-572.

共引文献7

同被引文献52

引证文献4

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部